Back to results
US 2026/0266829 A1Published application
C3F Assay
AssigneeNordic Bioscience A/S
InventorsRasmus Sund Petersen, Nicholas Willumsen, Morten Asser Karsdal
Life of this patent
Estimating the term…
Abstract
Disclosed herein are methods of immunoassay for detecting a fibroblast activation protein (FAP) generated fragment of type III collagen in a patient sample, and the use thereof for detecting and/or monitoring cancer or arthritis or a particular level of severity thereof in a patient. Also described are monoclonal antibodies and assay kits for use in said methods of immunoassay.
Claims17
A method of immunoassay, said method comprising;
- i) contacting a patient sample with a monoclonal antibody that specifically binds to the N-terminus amino acid sequence AGPAGAPGPA (SEQ ID NO:
- 1);
- and
- ii) detecting and determining the amount of binding between said monoclonal antibody and peptides in the sample.
1 more element
A monoclonal antibody that specifically binds to the N-terminus amino acid sequence AGPAGAPGPA (SEQ ID NO:
- 1).
Dependencies are inferred from the claim text.